Calyxt, Inc. (CLXT) Q3 2022 Earnings Call Transcript
Calyxt, Inc. (NASDAQ:NASDAQ:CLXT) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants William Koschak - CFO Michael Carr - President and CEO Presentation...
Stay updated with breaking news from Michaela Carr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Calyxt, Inc. (NASDAQ:NASDAQ:CLXT) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants William Koschak - CFO Michael Carr - President and CEO Presentation...
—Successfully produced squalene, an important ingredient for personal care products and vaccine adjuvants— —Continued to progress customer acquisition...
/PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT), a plant-based synthetic biology company, announced today that using a Calyxt-engineered Plant Cell Matrix™...
The agreement aims to power a speed-to-scale strategy to meet growing interest in high-quality sustainable ingredients across the cosmeceutical, nutraceutical and pharmaceutical markets.
/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that it has signed an agreement with its first...